NOTE: The following includes references to in the online news media. If you are interested in seeing the full article you will need to contact archives department of the source publication. We do not have copies of any articles described on this site.

Acambis (ACAM)

Acambis

Research and Markets : Acambis PLC - Pharmatrack
[excerpt] 30, 2004--Research and Markets (http://www.researchandmarkets.com/reports/c10285) has announced the addition of Acambis PLC - Pharmatrack to their offering. ... [/excerpt]
On Nov 30, 2004 in Business Wire (press release)

CDT bullish about under-par NASDAQ IPO
[excerpt] The company now joins an elite of East of England companies listed on the NASDAQ market, with heavyweights such as CAT, Acambis and ARM. ... [/excerpt]
On Dec 17, 2004 in Business Weekly

Hey, Modelman! Tune in to Sirius
[excerpt] Acambis (ACAM, news, msgs) , $9.76 -- John Sniegowski: â€œThis company invested quite a bit in 2004, and the earnings were not there to fully support it. ... [/excerpt]
On Dec 21, 2004 in MSN Money

This article appears in the following Subject Collections:
[excerpt] NIH "seems to be hell-bent on enforcing the regulations," says Thomas Monath, chief scientific officer at Acambis in Cambridge, Massachusetts, and president of ... [/excerpt]
On Dec 23, 2004 in Science Magazine (subscription)

Rhode Island Biotechnology Company Wins Second NIH BioDefense ...
[excerpt] Newer versions of the Jenner vaccine are being developed by other biotech companies (Acambis, Dynport) but these vaccines are also based on live attenuated ... [/excerpt]
On Dec 20, 2004 in Business Wire (press release)

New class of virus changes shape during infection
[excerpt] ...aiding their development. One particular area of promise is Acambisâ€™ ChimeriVax-Dengue vaccine. The â€œtetravalentâ€? vaccine ... [/excerpt]
On Dec 20, 2004 in Drug Researcher.com

Region has never had so many shooting stars
[excerpt] ...cent. Vaccines specialist Acambis is the second highest ranked East of England company in the European list in 26th place. Another ... [/excerpt]
On Dec 16, 2004 in Business Weekly

US Health Secretary Thompson Announces Resignation (Update5)
[excerpt] International Inc. and Acambis Plc to produce smallpox vaccine and negotiated a discount with Bayer AG to stockpile its Cipro antibiotic. He ... [/excerpt]
On Dec 3, 2004 in Bloomberg

Into the strong comes forth sweetness
[excerpt] 250. They replace smallpox vaccine manufacturer Acambis, high street retailer French Connection and telecoms operator Thus Group. ... [/excerpt]
On Dec 8, 2004 in Telegraph.co.uk

Tate & Lyle Joins Footsie Top Ranks
[excerpt] Moving from the FTSE 250 into the FTSE SmallCap index are vaccine maker Acambis, fashion retailer French Connection and business communications group Thus. ... [/excerpt]
On Dec 8, 2004 in The Scotsman

Medicago Inc. Announces New Board Member
[excerpt] He is currently a non-executive Director of Acambis (Listed on London Stock Exchange and NASDAQ) and ConjuChem Inc (listed on the Toronto Stock Exchange). ... [/excerpt]
On Nov 30, 2004 in mysan.de

US regulations will cost UK companies Â£450m
[excerpt] Smaller companies also covered include Provalis, the biotech group, Acambis, Eidos and ebookers. BT estimates that complying with the act will cost it Â£10m. ... [/excerpt]
On Nov 27, 2004 in Telegraph.co.uk,